agilon health, inc. (AGL)
NYSE: AGL · Real-Time Price · USD
87.89
-4.65 (-5.02%)
At close: Aug 31, 2026, 4:00 PM EDT
87.65
-0.24 (-0.27%)
After-hours: Aug 31, 2026, 7:52 PM EDT

agilon health Stock Forecast

Stock Price Forecast

According to 16 analysts polled by S&P Global, agilon health stock has a consensus rating of "Hold" and an average price target of $115.08. The average 1-year stock price forecast is 30.94% higher than the current stock price, while the lowest is $85 (-3.29%) and the highest is $146 (+66.12%).

Price Target: $115.08 (+30.94%)
Analyst Consensus: Hold

Price Target

Chart
TargetLowAverageMedianHigh
Price$85$115.08$115$146
Change-3.29%+30.94%+30.85%+66.12%

Analyst Ratings

The average analyst rating for agilon health stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Chart
RatingMar '26Apr '26May '26Jun '26Jul '26Aug '26
Strong Buy224444
Buy000000
Hold131311111011
Sell222221
Strong Sell000010
Total171717171716

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Bernstein
Bernstein
Hold
Reiterates
$86
HoldReiterates$86-2.15%Aug 28, 2026
J.P. Morgan
J.P. Morgan
Sell
Maintains
$31$85
SellMaintains$31$85-3.29%Aug 24, 2026
Truist Financial
Truist Financial
Hold
Maintains
n/a
HoldMaintainsn/an/aAug 24, 2026
Wells Fargo
Wells Fargo
Buy
Maintains
$141$146
BuyMaintains$141$146+66.12%Aug 11, 2026
Citi
Citi
Hold
Upgrades
$105$115
HoldUpgrades$105$115+30.85%Aug 10, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
5.81B
from 5.93B
Decreased by -1.99%
Revenue Next Year
6.25B
from 5.81B
Increased by 7.45%
EPS This Year
-0.45
from -21.86
EPS Next Year
2.06
from -0.45
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
1.52B2.39B4.32B6.06B5.93B5.81B
Revenue Growth
24.88%56.97%80.74%40.41%-2.11%-1.99%
Gross Profit
65.74M111.36M69.67M4.84M-160.02M221.92M
Gross Margin
4.32%4.66%1.61%0.08%-2.70%3.82%
Operating Income
-366.84M-102.91M-231.95M-283.96M-421.08M-76.88M
Net Income
-406.49M-106.55M-262.60M-260.15M-391.35M-32.25M
EPS
-----21.86-0.45
Free Cash Flow
4.09M-131.38M-64.40M-35.88M-81.23M-76.15M
No. Analysts
-----15
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High5.9B
Avg5.8B
Low5.7B

Revenue Growth

Revenue Growth202620272028
High
-1.3%
Avg
-2.0%
Low
-3.7%

EPS Forecast

EPS202620272028
High3.08
Avg-0.45
Low-4.81

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-